Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This research study is a Phase II clinical trial. Phase II clinical trials test the
effectiveness of an investigational combination of drugs. The purpose is to learn whether the
combination of drugs works in treating a specific cancer. "Investigational" means that the
combination of drugs is still being studied. It also means that research doctors are trying
to find out more about it. Examples of what they want to learn about are the safest dose to
use, the side effects it may cause, and if the combination of drugs works for treating
different types of cancer.